Speaker illustration

Miss Miriam Ruiz Ballester

Foundation for Health Research and Training, Murcia (Spain)

Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55/YY1/sST2 signaling axis

Event: Heart Failure 2024

Topic: Gene Therapy, Cell Therapy

Session: ePosters in basic science 1

Thumbnail